eli lilly zepbound tirzepatide Lilly's tops Wegovy for weight loss in head-to-head trial eli lilly tirzepatide direct Zepbound

Differences in study design, together with the relatively small number of participants receiving combined treatment, may limit the ability to detect synergistic effects

Follow the dosage escalation below to reduce the risk of gastrointestinal adverse reactions [see Warnings and Precautions (5.6) and Adverse Reactions (6.1)]

Protein intake of 1.2-1.5g per kg of body weight helps maintain health during treatment

This achievement sets a powerful benchmark for innovators and generics developers, bridging the gap between scientific complexity and regulatory expectations

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis